Free Trial

Norman Broadbent (NBB) Competitors

GBX 212.80 -2.20 (-1.02%)
As of 11:59 AM Eastern

NBB vs. IPEL, STEM, RWA, STAF, GATC, EMR, RTC, HAS, PAGE, and COST

Should you be buying Norman Broadbent stock or one of its competitors? The main competitors of Norman Broadbent include Impellam Group (IPEL), SThree (STEM), Robert Walters (RWA), Staffline Group (STAF), Gattaca (GATC), Empresaria Group (EMR), RTC Group (RTC), Hays (HAS), PageGroup (PAGE), and Costain Group (COST). These companies are all part of the "industrials" sector.

Norman Broadbent vs. Its Competitors

Impellam Group (LON:IPEL) and Norman Broadbent (LON:NBB) are both small-cap industrials companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

Norman Broadbent has a net margin of 2.02% compared to Impellam Group's net margin of 0.32%. Norman Broadbent's return on equity of 16.52% beat Impellam Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Impellam Group0.32% 7.78% 1.23%
Norman Broadbent 2.02%16.52%3.92%

In the previous week, Impellam Group's average media sentiment score of 0.00 equaled Norman Broadbent'saverage media sentiment score.

Company Overall Sentiment
Impellam Group Neutral
Norman Broadbent Neutral

8.4% of Impellam Group shares are owned by institutional investors. Comparatively, 34.3% of Norman Broadbent shares are owned by institutional investors. 85.8% of Impellam Group shares are owned by insiders. Comparatively, 41.7% of Norman Broadbent shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Impellam Group has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Comparatively, Norman Broadbent has a beta of -0.1, suggesting that its stock price is 110% less volatile than the S&P 500.

Impellam Group has higher revenue and earnings than Norman Broadbent. Impellam Group is trading at a lower price-to-earnings ratio than Norman Broadbent, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Impellam Group£2.04B0.00£15.70M£0.35N/A
Norman Broadbent£10.98M12.04£221.78K£0.38553.51

Summary

Impellam Group and Norman Broadbent tied by winning 5 of the 10 factors compared between the two stocks.

Get Norman Broadbent News Delivered to You Automatically

Sign up to receive the latest news and ratings for NBB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NBB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NBB vs. The Competition

MetricNorman BroadbentStaffing & Employment Services IndustryIndustrials SectorLON Exchange
Market Cap£132.20M£517.72M£7.78B£3.22B
Dividend Yield5.24%5.93%4.56%5.04%
P/E Ratio553.5146.3826.14164.63
Price / Sales12.04120.68102.08310,107.36
Price / Cash37.5014.6328.3727.93
Price / Book98.1310.224.095.90
Net Income£221.78K£10.32M£796.69M£5.89B
7 Day Performance3.30%1.48%0.60%48.33%
1 Month Performance9.13%3.84%1.19%49.98%
1 Year Performance2,940.00%153.97%27.76%127.65%

Norman Broadbent Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NBB
Norman Broadbent
N/AGBX 212.80
-1.0%
N/A+2,855.6%£132.20M£10.98M553.5152Gap Up
IPEL
Impellam Group
N/AN/AN/AN/A£389.29M£2.04B2,500.001,783
STEM
SThree
3.7788 of 5 stars
GBX 203
+0.2%
GBX 350
+72.4%
-50.4%£264.99M£1.47B5.372,280
RWA
Robert Walters
3.8026 of 5 stars
GBX 137
+1.9%
GBX 280
+104.4%
-61.4%£97.75M£1.07B15.813,980
STAF
Staffline Group
N/AGBX 45
-1.3%
N/A+25.3%£58.38M£896.86M-3.092,300
GATC
Gattaca
N/AGBX 96.04
-2.0%
N/A+5.1%£28.83M£370.86M155.09446
EMR
Empresaria Group
N/AGBX 40
-2.4%
N/A+7.8%£18.81M£235.95M-3.183,150
RTC
RTC Group
N/AGBX 91.50
-3.7%
N/A-2.0%£11.84M£90.27M6.45361Positive News
Gap Up
HAS
Hays
3.2814 of 5 stars
GBX 63.25
+0.9%
GBX 107.50
+70.0%
-34.2%£997.49M£6.91B-202.906,490News Coverage
Earnings Report
Analyst Forecast
Insider Trade
Gap Up
PAGE
PageGroup
N/AGBX 265.80
+0.8%
GBX 450
+69.3%
-36.4%£832.89M£1.87B16.457,859
COST
Costain Group
2.7153 of 5 stars
GBX 164
+1.0%
GBX 105
-36.0%
+27.7%£439.27M£1.28B14.643,270Trending News
Earnings Report
Analyst Forecast
Insider Trade

Related Companies and Tools


This page (LON:NBB) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners